TCNNF
Price
$8.10
Change
+$0.26 (+3.32%)
Updated
Dec 24 closing price
Capitalization
1.54B
62 days until earnings call
Intraday BUY SELL Signals
TSMRF
Price
Loading...
Change
-$0.00 (-0.00%)
Updated
Loading...
Capitalization
1.96B
Intraday BUY SELL Signals
Interact to see
Advertisement

TCNNF vs TSMRF

Header iconTCNNF vs TSMRF Comparison
Open Charts TCNNF vs TSMRFBanner chart's image
Trulieve Cannabis
Price$8.10
Change+$0.26 (+3.32%)
Volume$185.84K
Capitalization1.54B
Tsumura & Co
PriceLoading...
Change-$0.00 (-0.00%)
Volume$400
Capitalization1.96B
TCNNF vs TSMRF Comparison Chart in %
TCNNF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
TCNNF vs. TSMRF commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TCNNF is a Hold and TSMRF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 26, 2025
Stock price -- (TCNNF: $8.10 vs. TSMRF: $23.20)
Brand notoriety: TCNNF and TSMRF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: TCNNF: 19% vs. TSMRF: 100%
Market capitalization -- TCNNF: $1.54B vs. TSMRF: $1.96B
TCNNF [@Pharmaceuticals: Generic] is valued at $1.54B. TSMRF’s [@Pharmaceuticals: Generic] market capitalization is $1.96B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TCNNF’s FA Score shows that 1 FA rating(s) are green whileTSMRF’s FA Score has 1 green FA rating(s).

  • TCNNF’s FA Score: 1 green, 4 red.
  • TSMRF’s FA Score: 1 green, 4 red.
According to our system of comparison, TCNNF is a better buy in the long-term than TSMRF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TCNNF’s TA Score shows that 6 TA indicator(s) are bullish.

  • TCNNF’s TA Score: 6 bullish, 4 bearish.

Price Growth

TCNNF (@Pharmaceuticals: Generic) experienced а -27.18% price change this week, while TSMRF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.58%. For the same industry, the average monthly price growth was +8.11%, and the average quarterly price growth was +22.96%.

Reported Earning Dates

TCNNF is expected to report earnings on Feb 26, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.58% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TSMRF($1.96B) has a higher market cap than TCNNF($1.54B). TCNNF YTD gains are higher at: 56.265 vs. TSMRF (-17.584). TSMRF has higher annual earnings (EBITDA): 50.4B vs. TCNNF (322M). TSMRF has more cash in the bank: 73.2B vs. TCNNF (449M). TCNNF has less debt than TSMRF: TCNNF (813M) vs TSMRF (115B). TSMRF has higher revenues than TCNNF: TSMRF (182B) vs TCNNF (1.19B).
TCNNFTSMRFTCNNF / TSMRF
Capitalization1.54B1.96B79%
EBITDA322M50.4B1%
Gain YTD56.265-17.584-320%
P/E RatioN/A10.05-
Revenue1.19B182B1%
Total Cash449M73.2B1%
Total Debt813M115B1%
FUNDAMENTALS RATINGS
TCNNF vs TSMRF: Fundamental Ratings
TCNNF
TSMRF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
6
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9487
PRICE GROWTH RATING
1..100
3673
P/E GROWTH RATING
1..100
1578
SEASONALITY SCORE
1..100
3417

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TSMRF's Valuation (6) in the null industry is significantly better than the same rating for TCNNF (81). This means that TSMRF’s stock grew significantly faster than TCNNF’s over the last 12 months.

TSMRF's Profit vs Risk Rating (100) in the null industry is in the same range as TCNNF (100). This means that TSMRF’s stock grew similarly to TCNNF’s over the last 12 months.

TSMRF's SMR Rating (87) in the null industry is in the same range as TCNNF (94). This means that TSMRF’s stock grew similarly to TCNNF’s over the last 12 months.

TCNNF's Price Growth Rating (36) in the null industry is somewhat better than the same rating for TSMRF (73). This means that TCNNF’s stock grew somewhat faster than TSMRF’s over the last 12 months.

TCNNF's P/E Growth Rating (15) in the null industry is somewhat better than the same rating for TSMRF (78). This means that TCNNF’s stock grew somewhat faster than TSMRF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TCNNFTSMRF
RSI
ODDS (%)
Bearish Trend 3 days ago
81%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Momentum
ODDS (%)
Bullish Trend 3 days ago
78%
N/A
MACD
ODDS (%)
Bullish Trend 3 days ago
82%
N/A
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
13%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
12%
Advances
ODDS (%)
Bullish Trend 3 days ago
76%
N/A
Declines
ODDS (%)
Bearish Trend 5 days ago
87%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
80%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
TCNNF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FSRPX20.370.15
+0.74%
Fidelity Select Retailing
DFFVX37.610.09
+0.24%
DFA US Targeted Value I
SNTKX26.560.05
+0.19%
Steward Values Enhanced International A
ABEMX16.770.02
+0.12%
abrdn Emerging Markets Instl
QMGAX13.390.01
+0.07%
Invesco Advantage International A

TCNNF and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCNNF has been closely correlated with GTBIF. These tickers have moved in lockstep 83% of the time. This A.I.-generated data suggests there is a high statistical probability that if TCNNF jumps, then GTBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCNNF
1D Price
Change %
TCNNF100%
+3.32%
GTBIF - TCNNF
83%
Closely correlated
+5.03%
CURLF - TCNNF
80%
Closely correlated
-2.20%
TSNDF - TCNNF
76%
Closely correlated
+4.46%
CRLBF - TCNNF
75%
Closely correlated
+2.40%
JUSHF - TCNNF
73%
Closely correlated
-3.80%
More

TSMRF and

Correlation & Price change

A.I.dvisor tells us that TSMRF and TKPHF have been poorly correlated (+-0% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TSMRF and TKPHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSMRF
1D Price
Change %
TSMRF100%
N/A
TKPHF - TSMRF
-0%
Poorly correlated
N/A
TCNNF - TSMRF
-1%
Poorly correlated
+3.32%
TEVJF - TSMRF
-1%
Poorly correlated
N/A
VEXTF - TSMRF
-4%
Poorly correlated
-6.69%
LOVFF - TSMRF
-5%
Poorly correlated
N/A
More